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Although sputum smear microscopy is the primary 
method for tuberculosis (TB) diagnosis in low-resource 
settings, it has low sensitivity. The World Health Organ-
ization recommends the use of liquid culture techniques 
for TB diagnosis and drug susceptibility testing in low- 
and middle-income countries. An evaluation of samples 
from southern Sudan found that culture was able to detect 
cases of active pulmonary TB and extra-pulmonary TB 
missed by conventional smear microscopy. However, the 
long delays involved in obtaining culture results meant 
that they were usually not clinically useful, and high 
rates of non-tuberculous mycobacteria isolation made 
interpretation of results diffi  cult. Improvements in diag-
nostic capacity and rapid speciation facilities, either on-
site or through a local reference laboratory, are crucial.
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DIAGNOSIS of pulmonary tuberculosis (PTB) in 
r  esource-poor settings has traditionally relied on spu-
tum smear microscopy using the Ziehl-Neelsen (ZN) 
staining technique, which is inexpensive and not 
technically demanding. However, compared with cul-
ture, the method has low sensitivity,1 particularly in 
patients co-infected with the human immunodefi  ciency 
virus (HIV).2 ZN also has low sensitivity for diagnos-
ing extra-pulmonary tuberculosis (EPTB).3
In 2007, the World Health Organization (WHO) 
recommended the implementation of liquid culture 
techniques for diagnosis and drug susceptibility test-
ing of tuberculosis (TB) suspects in low- and middle-
income countries.4 The WHO observed that increased 
frequency of isolation of non-tuberculous mycobac-
teria (NTM) was a likely result of the highly sensitive 
culture system, and stated that a rapid method for 
differentiation of mycobacteria was essential. 
Médecins Sans Frontières (MSF) has worked in 
Sudan since 1979. Southern Sudan is affected by high 
levels of poverty, along with a lack of basic infra-
structure and services. The lack of roads and trans-
portation prevents access to health care services and 
can result in loss to follow-up of patients with chronic 
conditions such as TB. HIV prevalence varies be-
tween 0.4% and 4.4%.5 In 2008, 507 TB cases were 
admitted to MSF’s southern Sudan TB programme: 
30% of new cases were smear-positive, 5% were 
smear-negative and 65% were EPTB. 
In March 2007, MSF opened a TB culture labora-
tory in Lokichoggio, Kenya, with the support of the 
Borstel Supranational Reference Laboratory, Borstel, 
Germany, to serve basic health care projects in four 
locations in southern Sudan: Lankien and Pieri in 
Jonglei State, Nasir in Upper Nile State and Leer in 
Unity State. The aim was to enable diagnosis of EPTB 
and smear-negative PTB, improve TB treatment man-
agement decisions, and investigate suspected Myco-
bacterium bovis infection as a potential explanation 
for the high EPTB prevalence.
In the present study, we describe our experience, 
outcomes, and lessons learned to help to guide others 
with implementing TB culture in remote and resource-
poor settings.
METHODS 
From March 2007 to April 2009, TB culture was per-
formed on sputum samples from patients attend-
ing four MSF clinics in southern Sudan with clinical 
symptoms of smear-negative PTB or EPTB or with sus-
pected treatment failure. Positive cultures were sent to 
Borstel Reference Laboratory for speciation and qual-
ity control.
Two sputum samples were processed per PTB sus-
pect, and one extra-pulmonary sample (ascites or pleu-
ral fl  uid) was processed per EPTB suspect. Samples 
were collected at the clinics and refrigerated before 
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being sent in batches to the Lokichoggio laboratory. 
No preservatives were added. 
Sputum samples were decontaminated with N-
acetyl-L-cysteine sodium hydroxide (NaOH; fi  nal 
NaOH concentration 1.5%). All samples were cul-
tured using the manual Mycobacterial Growth Indi-
cator Tube (MGIT) system (BD Diagnostics, Sparks, 
MD, USA), and were cultured on Löwenstein-Jensen 
(LJ) medium in parallel. Stonebrink medium was 
used for the fi  rst 60 samples to enhance detection of 
M. bovis. Smears were made from fl  uorescing MGIT 
tubes and examined for presence of acid-fast bacilli 
and contaminants. LJ and Stonebrink tubes were ex-
amined visually for growth, and smears were made 
from colonies. One positive tube per patient was sent 
to the Borstel laboratory for speciation using the Hain 
GenoType Mycobacteria (Hain Lifesciences, Nehren, 
Germany) series and sequencing as required. For qual-
ity control, the reagents used were cultured with each 
batch to ensure sterility. No positive growth control 
was used.
Ethics approval was not obtained for this pro-
gramme description as all work described was done 
as part of routine programme activities.
RESULTS
Of 70 smear-negative diagnostic TB suspects, 23 
(33%) were culture-positive (Table). All three smear-
positive diagnostic patients were culture-positive. Pa-
tients on treatment had samples cultured to determine 
if viable bacteria could be isolated. Of 27 patients on 
treatment, seven were smear-positive, four of whom 
(57%) were culture-negative. Of 20 smear-negative pa-
tients on treatment, nine (45%) were culture-positive 
and 11 (55%) were culture-negative. Six of 20 smear-
negative EPTB samples were culture-positive. Only 
11 (29%) of 38 culture-positive PTB patients grew 
mycobacteria that could be identifi  ed as M. tuberculo-
sis complex, while three (50%) of six culture-positive 
EPTB patients grew M. tuberculosis complex (Table). 
The high proportion of NTM and unknown my-
cobacteria isolates could not be interpreted by clini-
cians, as it was not known whether the bacteria were 
disease-causing or environmental contaminants. That 
50% of the NTM could not be identifi  ed suggests 
that they were environmental contaminants and not 
clinically signifi  cant. They may have been introduced 
to the sputum samples through dust during collection 
or introduced to the suspects’ mouths through the 
water supply. Steps were taken to minimise environ-
mental contamination—suspects rinsed their mouths 
with fi  ltered water before expectoration, and expec-
torated directly into sterile Falcon tubes. EPTB sam-
ples were inoculated directly into prepared MGIT 
tubes, but their paucibacillary nature makes culture 
of these samples diffi   cult. There was a long turn-
around time (4–6 weeks) from sample production to 
speciation or a negative diagnosis, due to the shipment 
of samples from the projects to Lokichoggio, and of 
the positive cultures from Lokichoggio to Borstel. 
These delays led to concerns that TB suspects would 
be lost to follow-up, so smear-negative patients were 
put on treatment or had treatment adjusted according 
to clinical diagnosis rather than culture results. As a 
result, enrolment into the culture programme was sus-
pended in February 2009.
DISCUSSION
Our experience demonstrates that smear microscopy 
is failing to detect cases of active PTB and EPTB, and 
that implementation of culture in remote and resource-
limited settings is likely to face signifi  cant constraints. 
Because of the high recovery of NTM and lack of 
rapid on-site speciation facilities, a culture programme 
was of limited relevance for the diagnosis of smear-
negative and follow-up TB patients. However, culture 
did identify some TB patients who had been negative 
on smear microscopy. Clarifi  cation is needed on the 
management of NTM infection and the relevance of 
NTM isolation in these settings, as existing guidelines 
are diffi  cult to implement. The growth of NTM was 
unlikely to have resulted from laboratory contamina-
tion, owing to the variety of organisms isolated and 
the fact that we did not use a positive growth control. 
Table  Culture results by type of mycobacteria 
















M. tuberculosis complex   8 (11) 2 (67)   0 1 (14)*   3 (15)
Other identiﬁ  ed mycobacteria   7 (10)† 1 (33)‡  5  (25)§ 2 (29)¶  0
Other unknown mycobacteria   8 (11) 0   4 (20) 0   3 (15)
Culture-negative 47 (67) 0 11 (55) 4 (57) 14 (70)
* Plus M. fortuitum. 
† M. intracellulare (n = 1), M. asiaticum (n = 1), M. margaritense (n = 1), M. avium complex (n = 2) and M. fortuitum complex (n = 2). 
‡ M. fortuitum.
§ M. fortuitum complex (n = 4), M. avium complex (n = 1). ¶M. intracellulare (n = 1), M. fortuitum complex (n = 1). 
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NTM exist in the environment and may be present 
either in environmental dust or in the oral fl  ora of pa-
tients with poor oral hygiene. Methods to minimise 
exogenous contamination such as rinsing of mouths 
and expectorating into sterile containers were clearly 
insuffi  cient to completely prevent contamination. 
The time involved in obtaining results meant they 
were not clinically useful. However, culture was able 
to detect 11% of PTB and 15% of EPTB patients 
missed by conventional smear microscopy, emphasis-
ing the need for improvements in diagnostic capaci-
ties in resource-limited settings. As clinical data were 
not linked to samples, patient outcomes cannot be 
linked to the culture results. 
The WHO endorsed the use of line-probe assays 
for the rapid screening of multidrug resistance in 2008. 
Although molecular methods may have overcome the 
issues described here, they do not provide the growth 
control necessary for monitoring patients on treat-
ment, as DNA from non-viable bacilli can be ampli-
fi  ed. As line-probe assays can be used only on smear-
positive sputum samples, they cannot be used for 
monitoring smear-negative patients on treatment. 
Rapid speciation facilities, either on-site or through 
a local reference laboratory, are vital; however, until 
recently they were not readily available in many 
r  esource-limited settings. Until mid-2009, the only 
validated rapid immunochromatographic test for spe-
ciation (Tauns’ Capilia TB Neo, Tauns, Shizuoka, 
Japan) was available for purchase exclusively through 
the Foundation for Innovative New Diagnostics 
(FIND, Geneva, Switzerland), which limited availabil-
ity for implementation in routine culture programmes. 
New tests, such as the Becton Dickinson TBc Identifi  -
cation test (BD, USA), are now available on the mar-
ket, and other tests are under evaluation. 
When setting up a TB culture programme in a 
r  esource-limited setting, clear guidelines for the man-
agement of NTM results should be given to clinical 
staff. The recommendations of the American Tho-
racic Society and the Infectious Diseases Society of 
America6 for management of NTM isolates state 
that, along with clinical and radiographic symptoms 
of infection, the same species must be isolated in at 
least two samples to be considered clinically signifi  -
cant. This recommendation implies that, once a pa-
tient’s sample has been identifi  ed as growing NTM, 
the patient must submit a second sample for the same 
organism to be isolated again. This procedure was 
impractical in our setting because of the transport 
diffi  culties our patients commonly experienced when 
accessing our clinic, and the length of time involved 
in speciation. Chest X-ray facilities are uncommon in 
many resource-limited settings, which further prevents 
investigation of NTM infection according to current 
guidelines. 
The problems we encountered with culture, de-
spite our small sample size, are not exclusive to Su-
dan. A case-control study in Zambia7 found high 
rates of NTM isolation (11% of TB patients and 6% 
of controls). The most commonly isolated species 
was M. avium complex, but 55 of 171 species were 
unknown and not previously identifi   ed. In 22 of 
29 NTM-positive patients, only one of two consecu-
tive cultures was positive. As liquid culture laborato-
ries are further rolled out in low- and middle-income 
countries as per WHO recommendations, reaching 
more peripheral patients, the issues we encountered 
are likely to become more common. 
CONCLUSION
Implementation of culture as recommended by the 
WHO in remote and resource-limited settings is likely 
to face signifi  cant constraints due to the isolation of 
NTM which are of questionable clinical signifi  cance. 
Clear guidelines are needed to help national TB pro-
grammes with the interpretation of NTM isolation. 
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L’examen microscopique des frottis de crachats est la 
méthode principale de diagnostic de la tuberculose (TB) 
dans les contextes à faibles ressources, mais sa sensibilité 
est faible. Dans les pays à faibles ou moyens revenus, 
l’Organisation Mondiale de la Santé recommande l’uti-
lisation des techniques de culture sur milieu liquide pour 
le diagnostic de la TB ainsi que pour les tests de sensibi-
lité aux médicaments. Une évaluation des échantillons 
provenant du sud du Soudan a montré que la culture est 
capable de détecter des cas de TB pulmonaire active et 
de TB extrapulmonaire que l’examen microscopique 
conventionnel des frottis avait laissé échapper. Toute-
fois, les longs délais qu’implique l’obtention des résultats 
des cultures signifi  ent qu’elles n’ont habituellement pas 
eu d’utilité sur le plan clinique ; d’autre part, les taux 
élevés d’isolement de mycobactéries non-tuberculeuses 
ont rendu l’interprétation des résultats diffi  cile. Les amé-
liorations des capacités de diagnostic et des services de 
détermination rapide de l’espèce, que ce soit sur le site 




La baciloscopia del esputo constituye el principal mé-
todo diagnóstico de la tuberculosis (TB) en los ámbitos 
con escasos recursos, pero ofrece una baja sensibilidad. 
La Organización Mundial de la Salud recomienda el uso 
de técnicas de cultivo en medio líquido para el di-
agnóstico de la enfermedad y para las pruebas de sensibi-
lidad a los medicamentos antituberculosos en los países 
de bajos y medianos ingresos. En una evaluación de 
muestras provenientes del sur de Sudán, se observó que 
con el cultivo se pueden detectar los casos de TB activa, 
pulmonar y extrapulmonar, que pasaron desapercibidos 
con la baciloscopia convencional. Sin embargo, los plazos 
prolongados hasta la obtención de los resultados de los 
cultivos invalidaron su utilidad clínica y la alta tasa de 
aislamiento de micobacterias atípicas complicó la inter-
pretación de sus resultados. Es primordial mejorar la 
capacidad diagnóstica y contar con medios rápidos de 
diferenciación de las especies en el terreno o por inter-
medio de laboratorios locales de referencia.